Food and Drug Administration Grants

Food and Drug Administration · Up to $250K

An FDA R01 funding safety and effectiveness testing to support approval of drugs for minor uses or minor species (MUMS) in veterinary medicine. Eligibility is limited to entities developing such drugs (or their research partners) that already hold an INAD file and a MUMS designation from FDA/CVM, with a protocol pre-reviewed by FDA, so this requires existing regulatory standing with FDA. Awards reach up to about $250,000. Not a fit unless the applicant is already in the FDA veterinary drug development pipeline.

Food and Drug Administration · Up to $200K

This FDA cooperative agreement funds state and academic partners to strengthen antibiotic-resistance surveillance in retail food specimens as part of the NARMS program. Eligibility is broad, spanning universities, nonprofits (with or without 501(c)(3) status), small and large businesses, and state, local, and tribal governments. Awards range up to $200,000.

Food and Drug Administration · Up to $300K

This FDA cooperative agreement funds state animal food safety programs working toward or maintaining full implementation of national inspection standards, with optional add-ons for mutual-reliance partnerships. It's restricted to state programs that already hold an active FDA inspectional contract and a valid prior agreement — a narrow, technical bar that rules out most nonprofits and businesses. Awards go up to $300,000 depending on funding track and tier.

Food and Drug Administration · Up to $1.5M

An FDA cooperative agreement (Laboratory Flexible Funding Model) to strengthen state human and animal food testing laboratories through sample testing, food-defense preparedness, and method development. Eligibility is narrow: applicants must be ISO 17025 accredited (or have an equivalent quality system) and, for most tracks, hold a valid 20.88 agreement with FDA before applying. Awards run up to about $1.5 million. This is largely limited to established state food-testing laboratories that already meet the accreditation and FDA-agreement requirements.

Food and Drug Administration · Up to $600K

This FDA award (up to $600,000) funds natural history studies that generate high-quality data to support medical product development for rare diseases with unmet needs. Eligibility is very broad, covering universities, nonprofits (with or without 501(c)(3) status), small and other for-profit businesses, tribal and local/state governments, and even foreign organizations and their non-U.S. components. No unusual disqualifiers are noted, and the deadline is not imminent.

Food and Drug Administration · Up to $1.3M

Open to public and private higher-education institutions, including HBCUs, tribal colleges, and other minority-serving institutions. This FDA U18 forms long-term academic partnerships to research avian influenza and emerging zoonotic threats, intentional genomic alterations in animals, and products for minor and veterinary species. Awards up to about $1,250,000.

Food and Drug Administration · Up to $900K

Open to nearly any organization — universities, nonprofits (with or without 501(c)(3)), for-profits and small businesses, state/local/tribal governments, and foreign organizations. This FDA R01 funds clinical trials of orphan products evaluating safety and efficacy to address unmet needs in rare diseases. Awards up to about $900,000; clinical trials are required.

Food and Drug Administration · $225K–$2.5M

This FDA grant (U18, $225,000 to $2,500,000) funds veterinary diagnostic laboratories in the Vet-LIRN network to build capacity for animal food safety and antimicrobial resistance testing, including equipment and method development. Eligibility is broad, covering nonprofits (with or without 501(c)(3) status), small businesses, for-profit organizations, universities, tribal governments, and state/local governments. No unusual disqualifiers are noted, and the deadline is not imminent.

Food and Drug Administration · Amount varies

This is a forecasted FDA opportunity for applied regulatory science research to evaluate and treat the cardiotoxicity of oncology therapeutics. No eligibility details, funding amounts, or deadline have been published yet, so it is not currently open for applications. Watch for the full notice before preparing a proposal.

Food and Drug Administration · Amount varies

This is a forecasted (not yet open) FDA cooperative-agreement opportunity (U01) for health-equity research that does not involve clinical trials. Based on the U01 mechanism, awards typically go to research institutions, universities, and similar organizations rather than individuals or small businesses. Eligibility details, funding amounts, and deadlines have not yet been published, so check the official notice when it posts before assuming you qualify.

Food and Drug Administration · Amount varies

This is a forecasted FDA research opportunity (U01) to improve prediction of food-drug and drug-drug interaction risks using an in vitro gastrointestinal dissolution model for high-risk oral drugs; clinical trials are optional. Eligibility, award amounts, and deadlines are not yet published. U01 cooperative agreements typically fund universities and research institutions, so this is geared toward established research organizations.

Food and Drug Administration · Amount varies

This is a forecasted FDA opportunity for Animal Food Regulatory Program Standards implementation, development, and maintenance under the Mutual Reliance initiative. Eligibility, award amounts, and deadlines are not yet posted. Programs of this type typically fund state government regulatory programs that oversee animal food/feed safety, so eligibility is likely limited to government agencies; confirm in the full announcement.

Food and Drug Administration · Amount varies

This is an FDA forecast for a future Food Safety Capacity and Infrastructure Building opportunity (U2F); no eligibility, funding amount, or deadline has been published yet. It is expected to target food safety laboratories or public health organizations once the formal notice is released.

Food and Drug Administration · Amount varies

This is a forecast notice for a future FDA R01 research grant supporting efficient natural history studies for rare diseases; no eligibility, description, funding amount, or deadline has been published yet. Rare-disease researchers should watch for the full notice of funding opportunity, which will specify who may apply.

Food and Drug Administration · Amount varies

This is a forecasted (not yet posted) FDA opportunity titled Collaborations to Enhance Drug Development and Regulatory Science. Eligibility, award amounts, and deadlines have not yet been published. Programs of this type generally support research institutions and organizations doing drug development and regulatory science work, but applicants should wait for the full announcement to confirm details.

Food and Drug Administration · Amount varies

This Food and Drug Administration opportunity funds studies addressing rare neurodegenerative diseases, including amyotrophic lateral sclerosis (ALS), supporting research that advances understanding and treatment. It targets research institutions, academic medical centers, and similar organizations with relevant scientific capacity rather than individuals or small organizations. Detailed eligibility, award amounts, and deadlines are not published here because the opportunity is forecasted; confirm requirements in the official notice before applying.

Food and Drug Administration · Amount varies

This FDA opportunity is forecasted to support training delivery and development for the Integrated Food Safety System, likely aimed at state/local government agencies and organizations involved in food safety regulation and training. Because it is still in forecast status, detailed eligibility, funding amounts, and deadlines have not yet been published.

Food and Drug Administration · Amount varies

This is a forecasted FDA cooperative agreement supporting collaboration among retail food safety regulatory associations. Eligibility, funding amounts, and deadlines have not been published yet, and such awards typically go to professional associations or government-affiliated regulatory bodies. Confirm the full terms on Grants.gov once the announcement is released.

Food and Drug Administration · Amount varies

This is a forecasted FDA Office of Minority Health and Health Equity opportunity to fund a convener for a consortium focused on health equity for racial and ethnic minority populations (REACH). Eligibility, funding amounts, and deadlines have not yet been published, so applicants cannot confirm whether they qualify until the FDA releases the full announcement. Check Grants.gov for the official terms before planning an application.

Food and Drug Administration · Amount varies

This is a forecasted FDA research cooperative agreement (U01) to identify drug- and formulation-related factors causing alcohol-induced dose dumping in modified-release oral drugs; clinical trials are not allowed. Detailed eligibility, award amounts, and deadlines have not been published yet, and U01 mechanisms typically suit research institutions rather than general applicants. Confirm the full terms on Grants.gov once the announcement is released.